As a 501(c)(3) nonprofit, we depend almost entirely on donations from people like you.
We really need your help to continue this work! Please consider making a donation.
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Psychedelics, long ignored by scientists, seeing resurgence in medical research
Key Excerpts from Article on Website of San Francisco Chronicle (San Francisco's leading newspaper)


San Francisco Chronicle (San Francisco's leading newspaper), June 1, 2019
Posted: June 28th, 2019
https://www.sfchronicle.com/bayarea/article/Psychedelics-lon...

UCSF psychiatrist Brian Anderson is studying an experimental therapy to help long-term AIDS survivors ... who are feeling sad and demoralized. In a clinic outfitted with a comfortable couch, soft lighting, throw pillows and blankets, the participants of his study are given psilocybin, the hallucinogenic compound found in magic mushrooms. The results were compelling enough that hes planning a second study. Andersons work is part of a resurgence in psychedelic study that has been ... fueling grassroots efforts around the country to decriminalize use of certain psychedelic drugs. Statewide measures are being discussed in California and Oregon. The decriminalization efforts are focused on natural psychedelics mushrooms, along with herbs, cacti and other plants from which hallucinogenic compounds can be extracted. Though several studies in the first half of the 20th century had shown promise in using psychedelics for treatment of mental health and neurological disorders, the drugs were broadly maligned in the 1960s and 70s. More recently, microdosing the practice taking small, carefully controlled amounts of a psychedelic has taken off among Silicon Valley techies and university students who believe it boosts productivity and creativity. Almost all studies at the moment rely on private donations for funding. Studies are still limited, but theyre happening at universities around the country. At Johns Hopkins, Johnson and his colleagues reported about an 80% success rate in using psilocybin to help people quit smoking in one small study. Research out of UCLA has found that psilocybin may help cancer patients with depression and anxiety.

Note: For more along these lines, see concise summaries of deeply revealing news articles on studies of psychedelics from reliable major media sources.


Latest News


Key News Articles from Years Past